Board of Directors Ali Amin, MD ![]() I received my MD in Shiraz University of Medical Sciences (SUMS) in Iran, followed by an Anatomical/Clinical Pathology Residency in SUMS. After moving to the USA, I attended St. Lukes-Roosevelt Hospital for Pathology Residency, where I also served as a Chief Resident. Later on I finished a Surgical Pathology/Oncological Pathology Fellowship in Memorial Sloan Kettering Cancer Center, followed by Genitourinary Pathology Fellowship in the Johns Hopkins Hospital. I started my career in Brown University in 2011 where I currently hold the position of Associate Professor of Pathology and director of the GU pathology service. I am a member of a team of 25 pathologists, and our practice covers over 27,000 surgical specimens annually. I am involved in the training of medical students in Brown University, and have taken part in training of over 35 pathologists in training and over 12 urology residents. I served as the Secretary/Treasurer and President of the Rhode Island Society of Pathologists (RISP) (2013-2015) and as an Ambassador to the USCAP (2016-2018). Currently, I am a Rhode Island Delegate in CAP house of delegates. Sara Hafezi, MD
Sanam Loghavi, MD I am an Assistant Professor of Pathology and Laboratory Medicine at The University of Texas, MD Anderson Cancer Center. I received my MD degree from the Azad University in Tehran, Iran followed by residency training at Cedars Sinai Medical Center and fellowship training at MD Anderson Cancer Center. I subspecialize in hematopathology and molecular pathology and am actively involved in the fellowship training program. In addition to my clinical and teaching responsibilities I have several active administrative roles; I am the Medical Director of the Leukemia Bank at the Central Biorepository and Pathology Facility - ECOG-ACRIN and as a member of the Education Committee for the International Clinical Cytometry Society. I am passionate about medical education. My clinical and research interests are focused on hematologic malignancies, with particular focus on myeloid neoplasm and the applications of flow cytometric immunophenotyping and molecular methods in detection of minimal/measurable residual disease. I have authored over 100 peer-reviewed articles, 5 book chapters, and numerous abstracts in the fields of hematopathology and molecular pathology. I hope that these experiences will help me better serve the members of IPANA. Nima Sharifai, MD, PhD
Maryam J Zenali, MD
|